Diagnosis and Management of Liver Cirrhosis and Portal Hypertension: 2nd Edition
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 1554
Special Issue Editors
Interests: liver cirrhosis; liver diseases; cirrhosis; liver
Special Issues, Collections and Topics in MDPI journals
Interests: inflammatory bowel disease; ulcerative colitis; liver cirrhosis; gastrointestinal diseases; liver diseases; cirrhosis; liver failure; liver diseases and immunology
Special Issue Information
Dear Colleagues,
Chronic liver diseases impose a significant health burden worldwide, especially when they reach the stage of cirrhosis and portal hypertension. Age-standardised death rates from liver cirrhosis have declined over the last three decades in most regions of the world, most likely as a result of expanding knowledge and better healthcare; this, however, is except for Eastern Europe and Central Asia, which are facing elevated rates of heavy alcohol consumption. In the same period, the absolute number of deaths caused by cirrhosis increased by nearly 50%, representing 2.4% of all deaths in 2017, most likely reflecting the expansion of the world’s population and unmet needs in the field. Despite available vaccines and/or medications, viral hepatitis remains a challenging issue, and non-alcoholic fatty liver disease is becoming the leading cause of liver-related morbidity with multisystemic implications. The early identification, precise diagnosis, and prognostic stratification of this malady represent the most important steps towards the successful treatment and improved outcomes of patients with liver disease. The diagnostic landscape in hepatology has significantly changed, evolving from classical invasive methods, such as liver biopsy and hepatic venous pressure gradient measurements, to sophisticated non-invasive tools encompassing biochemistry, various “omics” approaches, and a myriad of ultrasound and magnetic resonance-based methods that are likely to be further enhanced by artificial intelligence. These steps forward in the diagnostic arena have been followed by equally exciting advances in therapeutic approaches, with novel compounds and devices having been introduced and others waiting to be evaluated and applied in clinical practice. The aim of this Special Issue of Diagnostics is to collate the current knowledge and apply it to cutting-edge research in the diagnosis and treatment of liver cirrhosis and portal hypertension, thus contributing to the global efforts to fight against these devastating conditions.
Prof. Dr. Ivica Grgurević
Prof. Dr. Mária Papp
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver cirrhosis
- portal hypertension
- esophageal varices
- ascites
- acute on chronic liver failure
- liver fibrosi
- liver steatosis
- liver biopsy
- proteomics in cirrhosis and portal hypertension
- genomics in cirrhosis and portal hypertension
- liver ultrasound
- liver elastography
- steatosis quantification
- non-invasive methods
- imaging in cirrhosis and portal hypertension
- magnetic resonance elastography
- contrast-enhanced ultrasound in cirrhosis and portal hypertension
- machine-based learning in cirrhosis and portal hypertension
- artificial intelligence in cirrhosis and portal hypertension
- treatment of cirrhosis and portal hypertension
